Piper Jaffray Downgrades Zimmer Biomet (ZBH) to Neutral
Piper Jaffray downgraded Zimmer Biomet (NYSE: ZBH) from Overweight to Neutral with a price target of $110.00 ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
